Funded Projects
| Funding Agency | Grant-ID | Title | Period | Amount INR. (Lakhs) | Status |
|---|---|---|---|---|---|
 Chief Minister's Research Grant, Tamil Nadu |
CMRG250931 | Novel strategy for the treatment of endemic skeletal fluorosis in Tamil Nadu by using drugs targeting the fluoride ion channel and exporter proteins (PI) | 2026 - 2029 | 32.55 | In progress |
 DBT, New Delhi |
BT/PR40156/BTIS/137/54/2023 | National Network Project of Alagappa University, Karaikudi (PI) | 2023 - 2028 | 144.56 | In progress |
DBT, New Delhi |
BT/PR40154/BTIS/137/34/2021 | Identification of Potent Drug for Life-Threatening diseases - BIC at Alagappa University, Karaikudi (Co-PI) | 2022 - 2027 | 183.88 | In progress |
 Higher Education, Govt. of Tamil Nadu |
No. 5594/H1/2020-1 | Scheme for Alternative Strategy to antibiotics in bacterial disease management at Alagappa University (Deputy-Coordinator) | — | 100.00 | Completed |
 TANSCHE, Chennai Govt. of Tamil Nadu |
TANSCHE-2021/117 | Identification of the vital targets of dengue and Chikungunya, an expanding threat to public health in Tamil Nadu: A potential drug discovery approach (PI) | May 2021 to October 2024 |
20.16 | Completed |
 MHRD-RUSA 2.0 Govt. of India |
F.24-51/2014-U | Mechanistic insights to understand the virus-host interaction and the identification of next-generation drugs to combat viral infections (PI) | 2018 - 2024 | 33.00 | Completed |
 MHRD, SPARC Govt. of India |
SPARC/2018-2019/P37/SL | Biophysics of Zika virus envelope protein, membrane fusion and inhibitor discovery (Co-PI) | 15 March 2019 to 2021 |
97.23 | Completed |
DBT, New Delhi |
No. BT/PR8138/BID/7/458/2013 | In-Silico screening, theoretical calculation and in vitro studies for development of potential HIV1-PR inhibitors (PI) | 10 Feb 2016 to 2019 |
19.51 | Completed |
DBT-Twin Project with IIT, Guwahati |
No. BT/502/NE/TBP/2013 | Identification of novel drug targets of Leishmania donovani: Studies on CAAX prenyl protease I and II of the pathogens (PI) | 11 Aug 2014 to 2018 |
73.69 | Completed |
 CSIR, New Delhi |
No. 37(1491)/11/EMR- II | QM/MM partial charges, binding pocket contours analysis and FEP calculation for designing potent inhibitors of HTLV- Protease: A De novo drug design approach (PI) | 2012 - 2015 | 16.02 | Completed |
 DST, New Delhi |
No. SR/FT/CS-66/2010 | Computational screening of CDK2 inhibitors by a combined approach of pharmacophoric study, quantum polarized ligand docking and molecular dynamics simulation study (PI) | 25 Jan 2011 to 2014 |
18.95 | Completed |
 UGC, New Delhi |
No. 39-548/2010 (SR) | Shape and chemical feature-based 3D-Pharmacophore Model generation, virtual screening and MESP studies to identify potential leads for antifungal azoles (PI) | 1 Feb 2011 to 2014 |
7.48 | Completed |
 AURF (UGC) With NIBI, Osaka, Japan |
No. A13/AURF/2009 | Pharmacophoric analysis and designing of ATP competitive CDK 4 inhibitors (PI) | 2009 - 2012 | 4.00 | Completed |